Drug manufacturer to launch commercial version of ‘natural painkiller’ Palmitoylethanolamide (PEA)

A large U.S. pharmaceutical company is preparing to go to market with a mass-produced commercial version of a natural pain management supplement that compounding pharmacies in Australia have been providing to integrative doctors and their patients for many years – Palmitoylethanolamide, or PEA. In November the drug manufacturer, Gencor, announced it had recently completed a 

Continue Reading…

Integrative vet uses PEA to treat chronic pain in pets – with encouraging results

We recently received a call from a pet owner curious to learn more about a compound called palmitoyletanolaminde, or PEA for short. Her integrative vet, Steve Denley from Balance Veterinary Care based in south east Queensland suggested they give PEA to her dog after he saw one of our articles on the subject. We contacted 

Continue Reading…

Forgotten pain-killing drug could fill gap in the market left by codeine crackdown

With codeine products no longer available over the counter at Australian chemists from today (1 Feb 2018), the compounding pharmacy sector may have a gentler, non-addictive answer for sufferers of chronic pain. The alternative pain-killing medication has a name that’s enough to cause you some additional pain – Palmitoylethanolamide. In clinical trials, this curious old 

Continue Reading…

Customising medication for better pain management

Health professionals in Australia are taking notice of a recent European study¹ which has demonstrated a link between ibuprofen and an increased risk of high blood pressure and cardiovascular disease in patients suffering arthritis. The study, released in August of this year by the European Society of Cardiology (ESC), found that patients receiving ibuprofen had 

Continue Reading…